Last updated: 2026-10-15 23:09:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $3.13, with a market capitalization of $14.97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $5.25. This page covers its latest market performance, valuation, price trends and company information.
$14.97M | |
$3.10 | |
$600.00 | |
$1.63 | |
$3.02 | |
10.16K | |
158.44K | |
-- | |
$5.25 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) is trading at $3.14 in after-hours trading as of 2026-10-15 21:12:00, up 3.94% ($0.12) from the regular-session close of $3.02.
After-hours trading shows how investors are pricing HSCS after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $3.77 to $3.13, representing a decline of 16.98% ($0.64).
The stock traded between $2.95 and $3.88 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 168.20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 41.4%
HSCS is currently trading at $3.13, placing it 41.4% of the way from its 52-week low of $1.63 to its 52-week high of $5.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | FINANCE SERVICES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.